Method of making water soluble injectable calcium polyphosphate gels

Patent metadata

Field	Value
Publication number	US-10052406-B2
Application number	US-201414900835-A
Country	US
Kind code	B2
Filing date	Jul 3, 2014
Priority date	Jul 3, 2013
Publication date	Aug 21, 2018
Grant date	Aug 21, 2018

Abstract

The present invention describes an injectable calcium polyphosphate (CPP) gel with dense structure, which can be applied as injectable bone void filler in medical field, such as orthopedic and dental applications. Amorphous CPP powder with fine particle size (<75 pm) can be completely dissolved in water, forming a homogeneous gelation phase separated from water phase. This homogeneous CPP gel with disentangled inorganic polyphosphate chains shows viscoelasticity and superior adhesion to natural bone, metal implant surfaces and other ceramic material surfaces. The CPP gel is biomimetic and biodegradable with strong osteoconductivity and osteoinductivity. The manufacturing procedure is easy and reproducible. The mechanical strength of CPP gel is controllable by modifications, such as sintering, incorporation of other biomaterials, etc.

First claim

The invention claimed is:

1. A composition for bone or soft tissue repair, the composition comprising:
a colloid, comprising amorphous calcium polyphosphate having a predetermined particle size mixed in an excess of aqueous fluid such that the colloid is injectable.

2. The composition according to claim 1 , wherein the colloid is water soluble and viscoelastic.

3. The composition according to claim 1 , wherein the amorphous calcium polyphosphate has a degree of polymerization of about 100.

4. The composition according to claim 1 , wherein the composition undergoes gelation after injection, and solidifies after about sixty minutes.

5. The composition according to claim 1 , further comprising a drug to be released after injection of the composition.

6. The composition according to claim 5 , wherein the drug is substantially fully released for at least 30 hours after injection.

7. The composition according to claim 1 , further comprising at least one of a metal, an organic compound, a polymer, and an inorganic ceramic material.

8. A composition for bone or soft tissue repair, the composition comprising:
a colloid comprising amorphous calcium polyphosphate having a predetermined particle size and a quantity of crystalline calcium polyphosphate mixed in an aqueous fluid to form a composite colloid, the colloid being injectable.

9. The composition according to claim 8 having a ratio of amorphous calcium polyphosphate to crystalline calcium polyphosphate between about 1:1 to about 10:1.

10. The composition according to claim 9 , wherein the ratio of amorphous calcium polyphosphate to crystalline calcium polyphosphate is about 2:1.

11. The composition according to claim 8 , wherein composite colloid comprises crystals of calcium polyphosphate dispersed therein.

12. The composition according to claim 8 , wherein the composite colloid sets to a solid within about 200 seconds when dried at about 37 degrees Celsius.

13. The composition according to claim 8 , further comprising at least one of a metal, an organic compound, a polymer, and an inorganic ceramic material.

14. The composition according to claim 8 , further comprising a drug to be released after injection of the composition, the drug being substantially fully released for at least 150 hours after injection.

15. A composition for bone or soft tissue repair, the composition comprising:
a colloid comprising amorphous calcium polyphosphate having a predetermined particle size mixed in an excess of aqueous fluid such that the colloid is injectable, the amorphous calcium polyphosphate being produced by calcining monobasic calcium phosphate.

16. The composition of claim 15 , wherein the monobasic calcium phosphate is calcined for about 4 hours to about 72 hours at a temperature of about 300 degrees Celsius to about 700 degrees Celsius.

17. The composition of claim 15 , wherein the colloid is water soluble.

18. The composition of claim 15 , wherein the amorphous calcium polyphosphate has a degree of polymerization of about 100.

19. The composition of claim 1 , wherein a ratio of aqueous fluid to amorphous calcium polyphosphate is about 2:1 to about 100:1.

20. The composition of claim 15 , wherein a ratio of aqueous fluid to amorphous calcium polyphosphate is about 2:1 to about 100:1.

Assignees

• Univ Wayne State

Inventors

• Ren Weiping
• Song Wei

Classifications

• A61L2430/34

  for soft tissue reconstruction · CPC title

• A61K9/5073

  having two or more different coatings optionally including drug-containing subcoatings · CPC title

• A61K9/1652

  Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623) · CPC title

• A61L27/52

  Hydrogels or hydrocolloids · CPC title

• A61L27/12 Primary

  Phosphorus-containing materials, e.g. apatite · CPC title